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massive pulmonary secretion during cardiac
surgery. A case report
Julien Teodori1*, Kamal Rampersad1, Giovanni Teodori1, Roland Roopchand1 and Gianni Davide Angelini2Abstract
A Indo-Caribbean patient undergoing cardiac surgery developed Transfusion Related Acute Lung Injury (TRALI) with
massive endobronchial secretion of clear fluid mimicking severe pulmonary edema. Hypoxemia and lung stiffness
were so severe that didn’t allow closure of the sternum on completion of surgery. The patient was treated with
invasive ventilation, high positive pressure and % FiO2 and aggressive endotracheal suction. After several hours,
secretions reduced spontaneously and the patient made an uneventful recovery.
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Transfusion Related Acute Lung Injury is a rare complica-
tion. The clinical pattern shows hypoxemia with bilateral
pulmonary infiltrations, producing large amount of secre-
tion mimicking cardiogenic pulmonary edema. Treatment
is usually supportive with invasive ventilation. Herein we
describe a patient with TRALI syndrome who was under-
going elective coronary artery bypass Surgery (CABG) and
the strategy adopted for its management.Case presentation
A 72 year-old Indo-Caribbean man with three-vessel cor-
onary artery disease underwent elective coronary artery
bypass surgery on the beating heart with left internal
mammary to the left anterior descending coronary artery
and a saphenous vein graft to the posterior descending
coronary artery.
Surgery was uneventful and the patient returned to
the intensive care unit in stable condition. Two hours
later, however, due to sudden bleeding and cardiac ar-
rest, he required resuscitation and re-exploration. In
order to control massive bleeding from a tear of the
aorta at the proximal venous anastomosis and the per-
sistent depressed cardiac function, it became necessary
to establish cardiopulmonary bypass. The hemoglobin* Correspondence: julien.teodori@gmail.com
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unless otherwise stated.(Hb) before re-exploration was 4.5 mg/dl. The tear in
the aorta was repaired, and the venous graft re-
implanted higher in the Ascending Aorta. Transfusion of
6 Units of packed red cells (PRC) and 3 Units of fresh
frozen plasma (FFP) was required to achieve Hb of
8.8 mg/dl at the end of surgery. Weaning from cardio-
pulmonary bypass was achieved with no inotropic sup-
port; however, it was difficult to ventilate the patient.
The lungs were very stiff and distended. Despite of high
positive pressure and % FiO2 the blood saturation
remained very low. This was soon followed by copious
pulmonary secretion requiring bronchial suction (around
100 ml of fluid collected each time), every 5 to 10 minutes.
The fluid was clear, yellowish, and not frothy. The total
amount of collected bronchial fluid before transfer to ICU
was over 1700 ml. An IABP was inserted, but any attempt
to close the chest resulted in significant decrease in the
systemic arterial pressure. The patient was therefore re-
turn to the intensive care unit with the chest open.
Repeated bronchial suctions were required for about five
hours before improvement in oxygen saturation. Bronchial
secretion reduced and then suddenly stopped two hours
after transfer to the ICU. Oxygenation improved and it
was possible to close the chest the following day. Respira-
tory distress remained and the patient was extubated on
day 5 postoperatively. He made a slow but uneventful re-
covery and was discharge home on day 20.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Transfusion related acute lung injury (TRALI) is a syn-
drome defined by acute pulmonary edema after transfu-
sion of any blood component [1] Suspect TRALI is
defined as fulfilmentof the definition of acute lung injury
occuring within 6 hours of transfusion, in the absence of
the other risk factors [2].
TRALI is considered one of the major causes of
transfusion-related morbidity with ABO incompatibility
and bacterial contamination, and the first cause of death
in U.S. [3]. Its incidence is similar in both sex and at any
age and is about 1 in 5000 transfusions [4]. The inci-
dence is probably underestimated due to lack of applica-
tion of diagnostic criteria.
The clinical pattern is dominated by acute respiratory
distress syndrome (ARDS). TRALI can be differentiated
from other forms of ARDS as invasive monitoring shows
normal intracardiac pressures. Lung damage is generally
transient and PO2 levels return to pre-transfusion levels
within 48–96 hours. The symptoms may occur during
6 hours after transfusion, showing dyspnoea, tachypnea,
hypotension and cyanosis [5]. Clinical exam shows se-
vere pulmonary distress but no signs of heart failure or
volume overload, confirmed by CXR analysis.
Treatment of TRALI is supportive with oxygen ther-
apy in the mild forms, and with mechanical ventilation
in the severe forms. Further blood product transfusion is
strongly discouraged. There is no evidence of benefit with
diuretics of corticosteroids [6]. Recovery is complete within
96 hours with no sequelae in the majority of the patients.
A small percentage may present persistent pulmonary infil-
trates up to seven days, and about 10% of cases have fatal
outcome despite aggressive support [7].
The pathophysiology of TRALI is based on activation
of neutrophil granulocytes at the onset of lung injury.
These are trapped in the pulmonary microcirculation
and oxygen free radicals and protheolitic enzymes are
released. Pulmonary capillary leak syndrome develops
with exudation of fluids and proteins. There are three
main theories supported in literature: the first theory
suggests the role of donor antibodies against recipient
leukocytes causing complement and neutrophil activa-
tion with subsequent endothelial damage. This theory is
supported by the presence of donorderived antibodies to
HLA class I antigens and neutrophils in up to 89% of
TRALI cases. The second theory is a “two hit hypoth-
esis” where the first hit is an underlying condition of the
patient with stimulation of adherence of neutrophils to
the pulmonary epithelium. The second hit is associated
with transfusion with reaction between antibody of the re-
cipient and surface antigens on RBCs donor causing imme-
diate degranulation of neutrophils [8]. Cardiopulmonary
Bypass used in cardiac surgery with its well-known sys-
temic inflammatory response can be considered as part ofthe “first hit”. The third hypothesis justifies the presence of
this syndrome also in neutropenic patients by suggesting
direct lung damage with endothelial fenestration, caused
by the presence of high levels of vascular endothelial
growth factor (VEGF) or antibodies to class II HLA anti-
gens in donor’s blood [9].
Prevention for this syndrome is difficult. The main pro-
cedures able to reduce the incidence of TRALI are the use
of predominantly male plasma for preparation of high-
volume plasma components and pooling of plasma prod-
ucts [10]. Other strategies planned are to reduce the use
of plasma from donors at high risk for HLA immunization
(i.e. previously pregnant females) and not to transfuse pa-
tients at risk (i.e. those in severe clinical condition) with
RBCs stored longer than 14 days or platelets stored longer
than 2 days.Conclusions
Transfusion Related Acute Lung Injury (TRALI) is a rare
but potentially lethal complication after heart surgery.
This case report highlights the need for conservative
management with mechanical ventilation of the lungs,
frequently repeated suction of secretion from the endo-
tracheal tube and avoidance of further transfusions.
Leaving the chest open facilitates lung ventilation and
minimises cardiovascular impairment.Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
The case description was performed in accordance to
the latest Declaration of Helsinki.
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